Leerink Partners Reiterates Market perform After Foundation Medicine (FMI) Reports Weak 2016 Guidance

February 24, 2016 9:35 AM

Leerink Partners reiterated a Market Perform rating on Foundation Medicine (NASDAQ: FMI), and cut the price target to $15.00 (from ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found